RxDoctor Payments Data

George Yamauchi

Los Angeles, CANPI 1952359283

Payments from drug & device makers

$2,527in general payments, 2019–2025

Across 104 payments — averaging $24.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$649
  • Astellas Pharma US Inc$463
  • Teleflex LLC$211
  • Boston Scientific$199
  • AbbVie$154
  • Coloplast$150
  • plus $701 from 15 others

What the payments were for

  • Food & beverage$2,33292%
  • Education$1948%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →